standards > terminology artifact > DOI:10.25504/FAIRsharing.ypfgeq


ready Translational Medicine Ontology

Abbreviation: TMO


General Information
This project focuses on the development of a high level patient-centric ontology for the pharmaceutical industry. The ontology should enable silos in discovery research, hypothesis management, experimental studies, compounds, formulation, drug development, market size, competitive data, population data, etc. to be brought together. This would enable scientists to answer new questions, and to answer existing scientific questions more quickly. This will help pharmaceutical companies to model patient-centric information, which is essential for the tailoring of drugs, and for early detection of compounds that may have sub-optimal safety profiles. The ontology should link to existing publicly available domain ontologies.



How to cite this record FAIRsharing.org: TMO; Translational Medicine Ontology; DOI: https://doi.org/10.25504/FAIRsharing.ypfgeq; Last edited: Feb. 22, 2018, 2:05 p.m.; Last accessed: Nov 15 2018 4:59 p.m.


Record updated: Jan. 18, 2017, 3:38 p.m. by The FAIRsharing Team.




Support

No support information provided.

Additional Information

External Links


Tools

    No tools defined


Schemas

No XSD schemas defined




Publications

No publications available


TMO Ontology Display

View in BioPortal.


Disclaimer: This widget assumes the availability of the ontology resources in the NCBO BioPortal.


Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


Implementing Databases (0)

No Related Databases


Implementing Policies

This record is not implemented by any policy.


Credit

Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.

Funds

Maintains